Promatix

Mablink Bioscience

This biotechnology firm develops antibody-drug conjugates for pharmaceutical companies to treat cancer using a proprietary hydrophilic linker platform.

LiliumX

This biotechnology company develops a discovery platform and bispecific antibody-drug conjugates for the treatment of cancer and other complex diseases.

Adcytherix

This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.

BiVictrix Therapeutics Plc

The company develops selective antibody-drug conjugates for the treatment of various cancers, including liquid and solid tumours, for the pharmaceutical and clinical sectors.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Avidicure

This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.